Upgrade to SI Premium - Free Trial

JPMorgan Downgrades Edwards Lifesciences (EW) to Neutral

July 25, 2024 3:13 AM
JPMorgan analyst Robbie Marcus downgraded Edwards Lifesciences (NYSE: EW) from Overweight to Neutral with a price target of $72.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades

Next Articles